Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.
about
Highly-parallel metabolomics approaches using LC-MS for pharmaceutical and environmental analysis.Development of the first metabolite-based LC-MS(n) urine drug screening procedure-exemplified for antidepressants.New Modified UPLC/Tandem Mass Spectrometry Method for Determination of Risperidone and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Dose-Dependent Pharmacokinetic Study in Sprague-Dawley RatsFragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry.Development and validation of amisulpride in human plasma by HPLC coupled with tandem mass spectrometry and its application to a pharmacokinetic study.Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control.Laboratory diagnostics in acute poisoning: critical overview.The analysis of antipsychotic drugs in human matrices using LC-MS(/MS).Development and validation of a multi-analyte LC-MS/MS approach for quantification of neuroleptics in whole blood, plasma, and serum.Degradation of zopiclone during storage of spiked and authentic whole blood and matching dried blood spots.Selective separation, detection of zotepine and mass spectral characterization of degradants by LC-MS/MS/QTOF.Sensitive quantification of clozapine and its main metabolites norclozapine and clozapine-N-oxide in serum and urine using LC-MS/MS after simple liquid-liquid extraction work-up.Electrochemical Characterization of Flupenthixol and Rapid Determination of the Drug in Human Serum and Pharmaceuticals by VoltammetryDetermination of Chlorpromazine, Haloperidol, Levomepromazine, Olanzapine, Risperidone, and Sulpiride in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
P2860
Q30380720-E365DE19-AED0-45C3-B873-753781FEB257Q30992027-F9A46BA6-E904-48E1-8C83-5D07CEDE5D68Q33695777-CC567849-F800-4FA4-AEA4-FD8C15F11A8DQ33811853-0F0DB6EF-04C6-49BC-8F5B-5867B53E44D6Q35185317-E75E7530-2422-469F-88EF-C8258EC7ACE6Q35970376-AF227BAF-8347-4E76-9BCE-D4D3ECE74A3DQ37775631-3138FA34-77C1-480F-9CDB-35FFD4786841Q38008991-8C6CAF04-7CB9-4D7E-8EC7-DCFE5B9E8523Q40274719-79A0FCFD-1D9C-4D43-9844-6658469B8E77Q44702071-230F2741-53BA-4BD2-9256-DF0EC22F9E54Q49696642-3F7C419E-C052-4B77-B9E8-CCDF34FE04DFQ53081839-15F17A2C-3FBD-40AF-B3CC-18469F3EB9D3Q58158164-203DC0A9-D3BE-4F86-A73C-FAE50FC8EA67Q58770172-61CE0D7A-3F09-42B9-B21F-E3BFB4FF7A7B
P2860
Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Screening, library-assisted id ...... pressure chemical ionization.
@ast
Screening, library-assisted id ...... pressure chemical ionization.
@en
type
label
Screening, library-assisted id ...... pressure chemical ionization.
@ast
Screening, library-assisted id ...... pressure chemical ionization.
@en
prefLabel
Screening, library-assisted id ...... pressure chemical ionization.
@ast
Screening, library-assisted id ...... pressure chemical ionization.
@en
P2093
P356
P1476
Screening, library-assisted id ...... c pressure chemical ionization
@en
P2093
Armin A Weber
Carsten Kratzsch
Frank T Peters
P304
P356
10.1002/JMS.440
P577
2003-03-01T00:00:00Z